1. Home
  2. IMMP vs MFH Comparison

IMMP vs MFH Comparison

Compare IMMP & MFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • MFH
  • Stock Information
  • Founded
  • IMMP 1987
  • MFH 2011
  • Country
  • IMMP Australia
  • MFH United States
  • Employees
  • IMMP N/A
  • MFH N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • MFH Finance: Consumer Services
  • Sector
  • IMMP Health Care
  • MFH Finance
  • Exchange
  • IMMP Nasdaq
  • MFH Nasdaq
  • Market Cap
  • IMMP 251.8M
  • MFH 273.9M
  • IPO Year
  • IMMP N/A
  • MFH N/A
  • Fundamental
  • Price
  • IMMP $1.76
  • MFH $4.94
  • Analyst Decision
  • IMMP Buy
  • MFH
  • Analyst Count
  • IMMP 1
  • MFH 0
  • Target Price
  • IMMP $7.00
  • MFH N/A
  • AVG Volume (30 Days)
  • IMMP 79.3K
  • MFH 388.8K
  • Earning Date
  • IMMP 10-21-2025
  • MFH 09-02-2025
  • Dividend Yield
  • IMMP N/A
  • MFH N/A
  • EPS Growth
  • IMMP N/A
  • MFH N/A
  • EPS
  • IMMP N/A
  • MFH N/A
  • Revenue
  • IMMP $3,019,249.00
  • MFH N/A
  • Revenue This Year
  • IMMP $50.37
  • MFH N/A
  • Revenue Next Year
  • IMMP N/A
  • MFH N/A
  • P/E Ratio
  • IMMP N/A
  • MFH N/A
  • Revenue Growth
  • IMMP 24.11
  • MFH 125.92
  • 52 Week Low
  • IMMP $1.32
  • MFH $1.03
  • 52 Week High
  • IMMP $2.72
  • MFH $8.86
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 52.82
  • MFH 64.00
  • Support Level
  • IMMP $1.63
  • MFH $4.29
  • Resistance Level
  • IMMP $1.85
  • MFH $4.72
  • Average True Range (ATR)
  • IMMP 0.07
  • MFH 0.38
  • MACD
  • IMMP -0.01
  • MFH 0.12
  • Stochastic Oscillator
  • IMMP 52.08
  • MFH 93.53

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About MFH Mercurity Fintech Holding Inc.

Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.

Share on Social Networks: